702 related articles for article (PubMed ID: 19191180)
21. Vernal keratoconjunctivitis in school children in Rwanda: clinical presentation, impact on school attendance, and access to medical care.
De Smedt SK; Nkurikiye J; Fonteyne YS; Tuft SJ; Gilbert CE; Kestelyn P
Ophthalmology; 2012 Sep; 119(9):1766-72. PubMed ID: 22683059
[TBL] [Abstract][Full Text] [Related]
22. [Cyclosporin A 2% eyedrops in therapy of atopic and vernal keratoconjunctivitis].
Tomida I; Schlote T; Bräuning J; Heide PE; Zierhut M
Ophthalmologe; 2002 Oct; 99(10):761-7. PubMed ID: 12376851
[TBL] [Abstract][Full Text] [Related]
23. [Vernal keratoconjunctivitis in children].
Oraszewska-Matuszewska B; Pieczara E; Sameochowiec-Donocik E; Filipek E
Klin Oczna; 2005; 107(1-3):86-9. PubMed ID: 16052811
[TBL] [Abstract][Full Text] [Related]
24. Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis.
Pucci N; Caputo R; Mori F; De Libero C; Di Grande L; Massai C; Bernardini R; Novembre E
Int J Immunopathol Pharmacol; 2010; 23(3):865-71. PubMed ID: 20943058
[TBL] [Abstract][Full Text] [Related]
25. Limbal vernal keratoconjunctivitis: clinical characteristics and immunoglobulin E expression compared with palpebral vernal.
Tuft SJ; Dart JK; Kemeny M
Eye (Lond); 1989; 3 ( Pt 4)():420-7. PubMed ID: 2606216
[TBL] [Abstract][Full Text] [Related]
26. Vernal keratoconjunctivitis.
Bonini S; Coassin M; Aronni S; Lambiase A
Eye (Lond); 2004 Apr; 18(4):345-51. PubMed ID: 15069427
[TBL] [Abstract][Full Text] [Related]
27. [Epidemiology of allergic eye diseases].
Bogacka E
Pol Merkur Lekarski; 2003 Jun; 14(84):714-5. PubMed ID: 14524314
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of vernal keratoconjunctivitis: a rare disease?
Bremond-Gignac D; Donadieu J; Leonardi A; Pouliquen P; Doan S; Chiambarretta F; Montan P; Milazzo S; Hoang-Xuan T; Baudouin C; Aymé S
Br J Ophthalmol; 2008 Aug; 92(8):1097-102. PubMed ID: 18356259
[TBL] [Abstract][Full Text] [Related]
29. [Epidemiological and clinical features of allergic conjunctivitis in a reference center].
Marback PM; de Freitas D; Paranhos Junior A; Belfort Junior R
Arq Bras Oftalmol; 2007; 70(2):312-6. PubMed ID: 17589705
[TBL] [Abstract][Full Text] [Related]
30. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H
J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889
[TBL] [Abstract][Full Text] [Related]
31. Allergic conjunctivitis: a cross-sectional study.
Leonardi A; Piliego F; Castegnaro A; Lazzarini D; La Gloria Valerio A; Mattana P; Fregona I
Clin Exp Allergy; 2015 Jun; 45(6):1118-25. PubMed ID: 25809830
[TBL] [Abstract][Full Text] [Related]
32. Vernal keratoconjunctivitis-like disease in adults.
Leonardi A; Lazzarini D; Motterle L; Bortolotti M; Deligianni V; Curnow SJ; Bonini S; Fregona IA
Am J Ophthalmol; 2013 May; 155(5):796-803. PubMed ID: 23352342
[TBL] [Abstract][Full Text] [Related]
33. Topical cyclosporine 0.5 per cent and preservative-free ketorolac tromethamine 0.5 per cent in vernal keratoconjunctivitis.
Kosrirukvongs P; Luengchaichawange C
J Med Assoc Thai; 2004 Feb; 87(2):190-7. PubMed ID: 15061303
[TBL] [Abstract][Full Text] [Related]
34. Ocular surface disease: a case of vernal keratoconjunctivitis.
Chigbu DI; Sandrasekaramudaly-Brown S
Cont Lens Anterior Eye; 2011 Feb; 34(1):39-44. PubMed ID: 20971677
[TBL] [Abstract][Full Text] [Related]
35. Impact of Vernal Keratoconjunctivitis on School Children in Egypt.
Marey HM; Mandour SS; El Morsy OA; Farahat HG; Shokry SM
Semin Ophthalmol; 2017; 32(5):543-549. PubMed ID: 27128625
[TBL] [Abstract][Full Text] [Related]
36. Tear chymase in vernal keratoconjunctivitis.
Ebihara N; Funaki T; Takai S; Miyazaki M; Fujiki K; Murakami A
Curr Eye Res; 2004 Jun; 28(6):417-20. PubMed ID: 15512949
[TBL] [Abstract][Full Text] [Related]
37. Development and testing of the quality of life in children with vernal keratoconjunctivitis questionnaire.
Sacchetti M; Baiardini I; Lambiase A; Aronni S; Fassio O; Gramiccioni C; Bonini S; Bonini S
Am J Ophthalmol; 2007 Oct; 144(4):557-63. PubMed ID: 17693381
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of 1.25% and 1% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood.
Spadavecchia L; Fanelli P; Tesse R; Brunetti L; Cardinale F; Bellizzi M; Rizzo G; Procoli U; Bellizzi G; Armenio L
Pediatr Allergy Immunol; 2006 Nov; 17(7):527-32. PubMed ID: 17014629
[TBL] [Abstract][Full Text] [Related]
39. Case series of 406 vernal keratoconjunctivitis patients: a demographic and epidemiological study.
Leonardi A; Busca F; Motterle L; Cavarzeran F; Fregona IA; Plebani M; Secchi AG
Acta Ophthalmol Scand; 2006 Jun; 84(3):406-10. PubMed ID: 16704708
[TBL] [Abstract][Full Text] [Related]
40. A Randomized, Controlled Trial of Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: The VEKTIS Study.
Leonardi A; Doan S; Amrane M; Ismail D; Montero J; Németh J; Aragona P; Bremond-Gignac D;
Ophthalmology; 2019 May; 126(5):671-681. PubMed ID: 30593775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
